We've reimagined the entire experience.
It’s the world’s first real-time, all-in-one diagnostic system that fits right into your clinic.
Behind the scenes, our cloud system double-checks the results and sends them straight to your electronic records.No delays. No missed follow-ups. Just fast, reliable answers — when they matter most.
Leadership
Ashraf joined Genalyte as Chief Executive Officer from Google Life Sciences (Verily) where he was Chief Operating Officer. Ashraf spent over a decade as a Vice President at Genentech leading portfolio planning, alliance management, and finance. He started his work career at McKinsey and Company, has a PhD in Physics from Harvard, and an M.D. from the University of Massachusetts.
Kevan brings nearly 25 years experience in life sciences technology research, development and commercialization. He started his career at Pacific Biosciences, a small, venture backed genomics startup and grew with the company through its first customer shipment and IPO. While there his work included basic research, manufacturing process development, enterprise IT system implementation and program management of multiple new product development programs. After PacBio, Kevan spent more than a decade in a variety of leadership roles at Illumina where he led multiple new product development programs and supervised research and engineering teams across the life sciences disciplines. Most recently, Kevan was responsible for a custom products, application development and partnerships team driving more than $300M in annual revenue.
Kevan holds a PhD in Applied and Engineering Physics from Cornell University and an MBA from The Wharton School, and was an undergrad at the University of Illinois at Urbana where he earned a BS in Physics and a BS in Computer Science and Mathematics.
Sam Rutten oversees all aspects of financial operations at Genalyte. He brings more than 15 years of finance and accounting experience with public and private companies in the life science and technology industries. Sam also leads administration operations and plays a major leadership role in the Company’s business strategy.
Sam has extensive operational leadership experience raising venture capital and developing strategic financial plans. He most recently served as Head of Finance and Controller at Roswell Biotechnologies where he led financial operations and was responsible for the IPO and commercialization readiness planning. Prior to that, Sam was with Fate Therapeutics where he led SEC reporting and SOX 404b implementation during the company’s rapid growth.
Before transitioning in-house, Sam worked as a senior business assurance associate at Moss Adams and Baker Tilly, where he worked with private and public life science clients. He holds a certified public accounting license and received a B.S. degree in corporate finance and accounting from the University of Wisconsin, La Crosse.
David joined Genalyte from Lucira Health, a diagnostic test developer, where he served as their Vice President of Regulatory and Clinical Affairs where successfully obtained the FDA’s first emergency use authorization for an at-home COVID-19 & Flu test, as well securing the first approval for their combination COVID & Flu Test by Health Canada and TGA (Australia).
Prior to joining Lucira Health, Davd spent the last 15 years in the Medical Device industry leading the Quality & Regulatory teams at companies such as Philips, DJO Global, Alphatec Spine and Henry Schein Orthodontics. Prior to his medical industry experience, David spent 16 years in the automotive and aerospace industries at Ford Motor Company, General Dynamics and Northup Grumman.
David received a B.S. from San Diego State University in Electrical Engineering, a Masters of Science in Reliability Engineering from the University of Maryland, and is a Certified Six Sigma Black Belt.
Dmitriy has a B.S. in Computer Engineering from UCSD and a Masters in Medical Device Engineering from UCSD also.
Dmitriy started his career working on software in the vehicle telematics space where he developed vehicle-to-vehicle and vehicle-to-infrastructure communications systems. He then moved into the medical device world.
Dmitriy held positions at Hospira as a tech lead leading development on one of the infusion pump platforms followed by a role as a tech-lead of the connectivity platform development at Outset Medical in support of their Tablo Dialysis system.
He then led platform software engineering teams at Auris Health, responsible for robotics and controls, infrastructure, platform software, data collection, operating systems, CI/CD etc. Some time after J&J acquired Auris, Dmitriy left to start his own venture (TraceMatrix) where his team developed a content management system with traceability for regulated industries. He sold/merged this company witn Enlil (Enlil.com) where he continued spearheading this development in a capacity of Sr Director of Product Development. After spending one year at Enlil following the acquisition, Dmitriy started with Genalyte where he leads the software organization in all areas pertaining to embedded, application, cloud and infrastructure, CI/CD development as well as software QA and regulatory compliance.
Board of Directors
Ready to see Merlin in action?
The power of a full-scale lab into a single, self-running device— designed to fit seamlessly into your existing workflow.
